Cargando…
Role of the splicing factor SRSF4 in cisplatin-induced modifications of pre-mRNA splicing and apoptosis
BACKGROUND: Modification of splicing by chemotherapeutic drugs has usually been evaluated on a limited number of pre-mRNAs selected for their recognized or potential importance in cell proliferation or apoptosis. However, the pathways linking splicing alterations to the efficiency of cancer therapy...
Autores principales: | Gabriel, Maude, Delforge, Yves, Deward, Adeline, Habraken, Yvette, Hennuy, Benoit, Piette, Jacques, Klinck, Roscoe, Chabot, Benoit, Colige, Alain, Lambert, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399393/ https://www.ncbi.nlm.nih.gov/pubmed/25884497 http://dx.doi.org/10.1186/s12885-015-1259-0 |
Ejemplares similares
-
The transcription factor c-Jun inhibits RBM39 to reprogram pre-mRNA splicing during genotoxic stress
por: Lemaitre, Florence, et al.
Publicado: (2022) -
Modulation of 5' splice site selection using tailed oligonucleotides carrying splicing signals
por: Gendron, Daniel, et al.
Publicado: (2006) -
Tumor microenvironment–associated modifications of alternative splicing
por: Brosseau, Jean-Philippe, et al.
Publicado: (2014) -
SRSF10: an atypical splicing regulator with critical roles in stress response, organ development, and viral replication
por: Shkreta, Lulzim, et al.
Publicado: (2021) -
Alternative splicing regulates the expression of G9A and SUV39H2 methyltransferases, and dramatically changes SUV39H2 functions
por: Mauger, Oriane, et al.
Publicado: (2015)